Westlake today announced the launch of its third fund of $450 million to incubate and grow early stage next-generation biotechnology companies in the Los Angeles region and beyond. The new fund will be managed by founding managing director Beth Seidenberg, M.D., managing director Mira Chaurushiya, Ph.D., and David Allison, Ph.D., who was recently appointed managing director.Read More
Westlake-Backed Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases
Westlake-backed Kate Therapeutics Inc., a next-generation gene therapy company, today emerged from stealth mode with a $51 million Series A financing co-led by founding investor Westlake Village BioPartners and Versant Ventures, with participation from Osage University Partners and UF Innovate | Ventures. In addition, the company has granted Astellas Pharma Inc. an exclusive, worldwide license to develop, manufacture and commercialize KT430 to treat X-linked myotubular myopathy (XLMTM), the details of which are described in a separate press release issued today.Read More
Our firm brings Silicon Valley access and experience to Los Angeles, an emerging biotech community that is fresh, unorthodox and exciting. From Silicon Beach to some of the most successful startups in biomedical history, the City of Angels is in the midst of becoming one of the world’s biotech hubs.
We are playing our part catalyzing the biopharma industry not just in the LA region but beyond. Technology can come from anywhere and we match our company building skills with interested entrepreneurs or academic centers.
From a leadership team that combines complementary skills in science and business with a track record of developing breakthrough products and high-value companies unlike anyone else in the life sciences venture community, we are forging new paths incubating and building life sciences companies that have the potential to bring transformative therapies and technologies to patients.
We want to work with people who have that same entrepreneurial spirit and passion to help patients in need; people who seek to push the boundaries of science and technology.
What we are looking for
New technologies and therapeutic approaches. We have broad and deep scientific expertise to nurture startups in virtually any therapeutic area of medicine and in all drug modalities.
Entrepreneurs with breakthrough ideas who want partners in building companies and getting their technology to patients as soon as practicable. We are open to anything that is new and focuses on a serious unmet patient need.
Tech transfer offices who want to work with experienced drug development and company building experts to commercialize science and technology to benefit patients.
If you feel we could be a good fit for you, your team and your technology, let’s discuss how what you are developing is going to make a real difference in the lives of patients and how we can work with you to make that happen.